Annual Shareholders Equity
$11.29 M
+$836.00 K+8.00%
31 December 2023
Summary:
Cyclerion Therapeutics annual stockholders equity is currently $11.29 million, with the most recent change of +$836.00 thousand (+8.00%) on 31 December 2023. During the last 3 years, it has fallen by -$48.20 million (-81.03%). CYCN annual shareholders equity is now -88.45% below its all-time high of $97.73 million, reached on 31 December 2019.CYCN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$8.20 M
-$585.00 K-6.66%
30 September 2024
Summary:
Cyclerion Therapeutics quarterly stockholders equity is currently $8.20 million, with the most recent change of -$585.00 thousand (-6.66%) on 30 September 2024. Over the past year, it has dropped by -$4.67 million (-36.32%). CYCN quarterly shareholders equity is now -94.19% below its all-time high of $141.19 million, reached on 30 June 2019.CYCN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYCN Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.0% | -36.3% |
| 3 y3 years | -81.0% | -85.5% |
| 5 y5 years | +208.1% | -93.1% |
CYCN Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -81.0% | +8.0% | -85.5% | +108.9% |
| 5 y | 5 years | -88.5% | +208.1% | -93.1% | +108.9% |
| alltime | all time | -88.5% | +208.1% | -94.2% | +178.5% |
Cyclerion Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.20 M(-6.7%) |
| June 2024 | - | $8.78 M(-11.5%) |
| Mar 2024 | - | $9.92 M(-12.1%) |
| Dec 2023 | $11.29 M(+8.0%) | $11.29 M(-12.3%) |
| Sept 2023 | - | $12.87 M(+150.0%) |
| June 2023 | - | $5.15 M(+31.2%) |
| Mar 2023 | - | $3.92 M(-62.4%) |
| Dec 2022 | $10.45 M(-78.3%) | $10.45 M(-36.7%) |
| Sept 2022 | - | $16.52 M(-34.8%) |
| June 2022 | - | $25.36 M(-31.5%) |
| Mar 2022 | - | $37.03 M(-23.2%) |
| Dec 2021 | $48.25 M | $48.25 M(-14.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $56.39 M(-13.5%) |
| June 2021 | - | $65.22 M(+34.7%) |
| Mar 2021 | - | $48.43 M(-18.6%) |
| Dec 2020 | $59.49 M(-39.1%) | $59.49 M(-21.0%) |
| Sept 2020 | - | $75.35 M(+14.0%) |
| June 2020 | - | $66.10 M(-18.9%) |
| Mar 2020 | - | $81.54 M(-16.6%) |
| Dec 2019 | $97.73 M(-1035.7%) | $97.73 M(-18.0%) |
| Sept 2019 | - | $119.20 M(-15.6%) |
| June 2019 | - | $141.19 M(-1921.3%) |
| Mar 2019 | - | -$7.75 M(-25.8%) |
| Dec 2018 | -$10.45 M(+21.9%) | -$10.45 M |
| Dec 2017 | -$8.57 M | - |
FAQ
- What is Cyclerion Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics annual shareholders equity year-on-year change?
- What is Cyclerion Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics quarterly shareholders equity year-on-year change?
What is Cyclerion Therapeutics annual stockholders equity?
The current annual shareholders equity of CYCN is $11.29 M
What is the all time high annual shareholders equity for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high annual stockholders equity is $97.73 M
What is Cyclerion Therapeutics annual shareholders equity year-on-year change?
Over the past year, CYCN annual stockholders equity has changed by +$836.00 K (+8.00%)
What is Cyclerion Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CYCN is $8.20 M
What is the all time high quarterly shareholders equity for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high quarterly stockholders equity is $141.19 M
What is Cyclerion Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CYCN quarterly stockholders equity has changed by -$4.67 M (-36.32%)